$Athira (ATHA.US)$ NEWS Athira Pharma Announces Publication ...
NEWS
Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
Athira Pharma, Inc. announces promising preclinical data on fosgonimeton for Alzheimer's disease treatment. Fosgonimeton shows neuroprotective effects, counteracts Aβ-induced toxicity, and enhances neuronal health. Key findings include improved neuronal survival, reduced tau hyperphosphorylation, enhanced activation of pro-survival effectors, and cognitive improvement in preclinical models.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
591Followers
69Following
3755Visitors
Follow